Clik here to view.
DNAnexus Platform Powers Garvan Institute’s Move to Provide Global Genomic...
MOUNTAIN VIEW, Calif. DNAnexus Inc., a pioneer in cloud-based genome informatics and data management, today announced that the Garvan Institute of Medical Research in Sydney, Australia is now using...
View ArticleClik here to view.
FUJIFILM Recieves ONC HIT 2014 Edition Complete EHR Certification for Synapse...
STAMFORD, Conn. FUJIFILM Medical Systems U.S.A., Inc. has received ONC HIT 2014 Edition Complete EHR certification for Synapse RIS Version 6.3.3., which designates that the software is capable of...
View ArticleClik here to view.
Santen Chooses NTT Communications’ Hybrid-cloud ICT Infrastructure for Global...
TOKYO NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (NYSE:NTT), announced today that it has constructed an ICT backbone...
View ArticleClik here to view.
セカンド・サイトが2015年3月9日の第27回ROTH年次大会でプレゼンへ
米カリフォルニア州シルマー （ビジネスワイヤ） — 盲目の患者に視機能を提供する植え込み型視覚補綴物を開発・製造・販売するセカンド・サイト・メディカル・プロダクツ（NASDAQ:EYES）（「セカンド・サイト」または「当社」）は本日、社長兼最高経営責任者（CEO）のDr. Robert...
View ArticleClik here to view.
Second Sight将于2015年3月9日在ROTH第27届年会上呈报
加州SYLMAR (美国商业资讯) — Second Sight Medical Products, Inc. (NASDAQ:EYES) （”Second Sight”或”公司”）是为失明患者提供视觉功能的植入式视觉假体的开发者、制造商和营销商，该公司今天宣布，公司总裁兼首席执行官Robert Greenberg博士将在ROTH资本合伙人第27届年会上呈报，详情如下： 日期：...
View ArticleClik here to view.
14th Annual International Forum on Consciousness Topic Announced, Conscious...
MADISON, Wis. Join scientists, writers, religious leaders, futurists and other global experts in examining the mysteries of consciousness and how we may participate in shaping our collective future...
View ArticleClik here to view.
Gore公司的全球血管内主动脉治疗备案库纳入患者达到2,500例
亚利桑那州FLAGSTAFF (美国商业资讯)–据W. L. Gore & Associates, Inc. (Gore) 报告，Gore 公司的全球血管内主动脉治疗备案库(GREAT)纳入的患者已超过2,500例。Gore公司致力于器械性能的上市后监测和长期监察，以求改善临床实践和患者疗效，该备案库是这一执着的组成部分。自2010年8月以来，...
View ArticleClik here to view.
Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results...
CAMBRIDGE, Mass. & STOCKHOLM Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today announced positive top-line results of the Kids B-LONG Phase 3 clinical...
View ArticleClik here to view.
CHMP RECOMMENDS JINARC® (TOLVAPTAN) FOR APPROVAL IN EU: THE FIRST...
TOKYO Otsuka Pharmaceutical Co., Ltd. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended JINARC® (tolvaptan) for...
View ArticleClik here to view.
「大動脈血管内治療のためのゴア・グローバルレジストリー」の登録患者が2500人を超える
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は、Gore Global Registry for Endovascular Aortic...
View ArticleClik here to view.
TOMI™ Environmental Solutions, Inc. Announces Expansion into the Philippines...
BEVERLY HILLS, Calif. TOMI™ Environmental Solutions, Inc. (“TOMI™” or “the “Company”) (OTCQB: TOMZ), a global bacteria and infectious disease control company, announced today that it has entered...
View ArticleClik here to view.
New Partnership with Meyra Extends Aesynt’s IV Robotics Footprint to the...
CRANBERRY TOWNSHIP, Pa. Aesynt, a leading provider of integrated pharmacy automation solutions for hospitals and health systems, today announced a new strategic partnership with Meyra to market...
View ArticleClik here to view.
NDS Surgical Imaging Announces New 27” Radiance® Ultra, a Revolutionary...
SAN JOSE, Calif. NDS Surgical Imaging (NDSsi) today announced the release of its highly anticipated 27” Radiance® Ultra, a next-generation surgical visualization platform boasting the brightest LED...
View ArticleClik here to view.
Novacyt and Leica Biosystems Sign Major Distribution Deal for NOVAprep® in...
PARIS & CAMBRIDGE, England Novacyt (ALTERNEXT:ALNOV), an international specialist in cancer and infectious disease diagnostics, and Leica Biosystems, a leading supplier to the pathology market,...
View ArticleClik here to view.
Acucela to Hold 2015 Annual Meeting of Shareholders on June 8, 2015
SEATTLE Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of...
View ArticleClik here to view.
Eisai and Merck Enter Collaboration to Explore Novel Combination Regimens of...
TOKYO & KENILWORTH, N.J. Eisai Co., Ltd. and Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, through a subsidiary, announced today a clinical trial collaboration to evaluate the...
View ArticleClik here to view.
Mauli Ola Foundation Bringing Natural Therapies to the Gold Coast of Australia
LAGUNA BEACH, Calif. Mauli Ola Foundation (“Mauli Ola”), a 501c(3) non-profit organization based out of Laguna Beach, California, that supports those with genetic disorders, has landed on the Gold...
View ArticleClik here to view.
R-Tech Ueno: The End of a Phase 3 Clinical Study and Preliminary Findings...
TOKYO R-Tech Ueno (JASDAQ: 4573) announced today the end of a Phase 3 clinical study with Unoprostone (development code UF-021) ophthalmic solution that are being developed in our company for the...
View ArticleClik here to view.
Delaware Court Finds That THERAVECTYS is Reasonably Likely to Succeed on the...
PARIS THERAVECTYS announced today a ruling by the Delaware Court of Chancery on the motion for preliminary injunction filed by THERAVECTYS against Immune Design Corp. (“IDC”) in a lawsuit filed in...
View ArticleClik here to view.
Open Monoclonal Technology Announces OmniAb™ Alliance with Celgene
PALO ALTO, Calif. Open Monoclonal Technology, Inc. (OMT) today announced a license that provides Celgene Corporation (Celgene) with unlimited access to OMT’s proprietary OmniRat®, OmniMouse® and...
View Article